Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
100.00%
↑ 531% vs avg
Percentile
P90
Near historical high
Streak
3 qtr
Consecutive growthAccelerating
Average
-23.20%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 100.00% |
| Q3 2025 | 7.66% |
| Q2 2025 | -16.56% |
| Q1 2025 | -452.37% |
| Q4 2024 | 64.13% |
| Q3 2024 | -11.87% |
| Q2 2024 | -37.76% |
| Q1 2024 | -388.38% |
| Q4 2023 | -65.28% |
| Q3 2023 | 57.90% |
| Q2 2023 | 31.16% |
| Q1 2023 | 211.15% |
| Q4 2022 | -39.69% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | -100.00% |
| Q2 2021 | 400.00% |
| Q1 2021 | 101.52% |
| Q4 2020 | -2.87% |
| Q3 2020 | -39.13% |
| Q2 2020 | -93.68% |
| Q1 2020 | -59.81% |
| Q4 2019 | -527.00% |
| Q3 2019 | -61.31% |
| Q2 2019 | 59.32% |
| Q1 2019 | -64.43% |
| Q4 2018 | 195.59% |
| Q3 2018 | -45.73% |
| Q2 2018 | 0.97% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | -68.56% |
| Q2 2017 | 13.13% |
| Q1 2017 | 28.85% |
| Q4 2016 | 0.00% |
| Q3 2016 | -25.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |